Search research articles
Contact Us
Filters
Showing results (101-110 of 163) with videos related to
Page
of 17
Sort By:
Therapeutic Advances in Neurological Disorders
|
September 6, 2021
Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke
Simon Fandler-Höfler, Rudolf E Stauber, Markus Kneihsl, et al.
Journal of Hepatology
|
June 30, 2019
Obeticholic acid may increase the risk of gallstone formation in susceptible patients
Samer Al-Dury, Annika Wahlström, Katrin Panzitt, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
July 9, 2005
Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver
Gernot Zollner, Martin Wagner, Peter Fickert, et al.
Gastroenterology
|
October 3, 2002
Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles
Peter Fickert, Gernot Zollner, Andrea Fuchsbichler, et al.
The American Journal of Pathology
|
June 30, 2007
A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis
Peter Fickert, Ulrike Stöger, Andrea Fuchsbichler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 19, 2023
Fungal translocation measured by serum 1,3-ß-D-glucan correlates with severity and outcome of liver cirrhosis-A pilot study
Matthias Egger, Angela Horvath, Florian Prüller, et al.
Tropical Medicine & International Health : TM & IH
|
September 15, 2009
Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis
Micha Loebermann, Martina Sombetzki, Cord Langner, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 28, 2012
Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model
Johannes Haybaeck, Cornelia Stumptner, Andrea Thueringer, et al.
Hepatology (Baltimore, Md.)
|
October 19, 2011
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output
Anna Baghdasaryan, Thierry Claudel, Judith Gumhold, et al.
The Journal of Pathology
|
June 26, 2015
Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction
Yu Chen, Nurdan Guldiken, Manuela Spurny, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 163) with videos related to
Sort By:
Page
of 17
Therapeutic Advances in Neurological Disorders
|
September 6, 2021
Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke
Simon Fandler-Höfler, Rudolf E Stauber, Markus Kneihsl, et al.
Journal of Hepatology
|
June 30, 2019
Obeticholic acid may increase the risk of gallstone formation in susceptible patients
Samer Al-Dury, Annika Wahlström, Katrin Panzitt, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
July 9, 2005
Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver
Gernot Zollner, Martin Wagner, Peter Fickert, et al.
Gastroenterology
|
October 3, 2002
Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles
Peter Fickert, Gernot Zollner, Andrea Fuchsbichler, et al.
The American Journal of Pathology
|
June 30, 2007
A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis
Peter Fickert, Ulrike Stöger, Andrea Fuchsbichler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 19, 2023
Fungal translocation measured by serum 1,3-ß-D-glucan correlates with severity and outcome of liver cirrhosis-A pilot study
Matthias Egger, Angela Horvath, Florian Prüller, et al.
Tropical Medicine & International Health : TM & IH
|
September 15, 2009
Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis
Micha Loebermann, Martina Sombetzki, Cord Langner, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 28, 2012
Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model
Johannes Haybaeck, Cornelia Stumptner, Andrea Thueringer, et al.
Hepatology (Baltimore, Md.)
|
October 19, 2011
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output
Anna Baghdasaryan, Thierry Claudel, Judith Gumhold, et al.
The Journal of Pathology
|
June 26, 2015
Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction
Yu Chen, Nurdan Guldiken, Manuela Spurny, et al.
Page
of 17